The HFCD initiated a metabolic cascade of elevated lipid profiles, hypertriglyceridemia, hyperglycemia, oxidative stress, insulin, and inflammatory biomarkers implicated in insulin resistance and NAFLD. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.